Abstract submission for our next annual congress is now open! EAN Programme Committee Chair, Prof. Ulf Kallweit shares the details on this and other latest news about EAN 2023.
-
-
Paper of the MonthEAN NewsFeatured SliderResearch Paper of the Month: Lecanemab in Early Alzheimer’s Disease
Our authors of the month report the results of a multicentre phase-3 clinical trial exploring efficacy and safety of Lecanemab in patients with early AD over a follow-up period of eighteen months. -
Paper of the MonthEAN NewsCOVID-19Featured SliderCovid-19 Paper of the Month: Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis
Our authors of the month conducted a retrospective study of the potential association between COVID-19 and seizures or epilepsy in the six months after infection, using an electronic health records network of 81 million people. -
Executive PageEAN NewsFeatured SliderExecutive Page: New guideline prioritisation process begins setting path for next two years
EAN Scientific Committee Chair, Prof. Thomas Berger, provides a general update, including guideline prioritisation news, ongoing research projects and the forthcoming 2nd EAN Science School. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion
Our research paper of the month presents the results of the Endovascular Treatment for Acute Basilar-Artery Occlusion (ATTENTION) trial; a multicentre, prospective, randomised and open-label trial, conducted in 36 Chinese centres. -
Paper of the MonthEAN NewsCOVID-19Featured Slider
Covid-19 Paper of the Month: Post-acute sequelae of covid-19 six to twelve months after infection
The authors of our Covid paper of the month conducted this cross sectional study in southern Germany involving people aged 18–65, confirming the existence of a considerable burden of self-reported post-acute symptom clusters -
Executive PageEAN NewsFeatured SliderExecutive Page: More reasons than ever to renew your EAN membership
EAN Secretary General, Tony Marson, provides a general update on membership issues, including new membership benefits and the opening of this year's membership renewal period.. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: EAN/MDS-ES guideline on the treatment of Parkinson’s disease: I. Invasive therapies
This month we have selected the guidelines dedicated to the invasive therapeutic pathways for Parkinson's disease, published jointly by the EAN and the Movement Disorder Society-European Section. -
Paper of the MonthEAN NewsCOVID-19Featured Slider
Covid-19 Paper of the Month: Vestibular syndromes after COVID-19 vaccination: A prospective cohort study
Our paper of the month for October investigates vestibular function in patients with dizziness, vertigo and postural symptoms following COVID-19 vaccination. -
Executive PageEAN NewsFeatured SliderExecutive Page: Challenge of maintaining high standards is a privilege says incoming Education Committee Chair
New EAN Education Committee Chair, Irena Rektorova, introduces herself with an overview of recent and upcoming EAN educational initiatives. -
Paper of the MonthEAN NewsFeatured Slider
Research Papers of the Month: ‘Trial of Cinpanemab in Early Parkinson’s Disease’ and ‘Trial of Prasinezumab in Early-Stage Parkinson’s Disease’
This month we have selected two phase-2 trials investigating α-synuclein-binding antibodies as potential disease-modifying treatment of Parkinson’s disease. -
Paper of the MonthEAN NewsCOVID-19Featured Slider
Covid-19 Paper of the Month: Risk of SARS-CoV-2 infection, hospitalization, and death for COVID-19 in people with Parkinson disease or parkinsonism over a 15-month period
Our authors of the month for September conclude that people with Parkinson's Disease and parkinsonism showed a higher risk of SARS-CoV-2 infection throughout the first 15 months of the pandemic. -
Executive PageEAN NewsFeatured SliderExecutive Page: New President-Elect outlines aims for EAN’s future agenda
The new EAN President-Elect highlights some hopes and objectives for the future of the EAN, including updates on the work of the Covid-19 Task Force and the Coordinating Panel on Diversity, Equity and Inclusion in Neurology. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke
Our research paper of the month presents the results of the ‘SWIFT direct’ trial, a randomised, open-label, blinded-outcome trial, aiming to investigate whether thrombectomy alone would be non-inferior to thrombectomy plus intravenous alteplase in patients with acute ischaemic stroke due to anterior circulation large vessel occlusion. -
Executive PageBrain HealthEAN NewsEAN Congress newsTop ArticlesFeatured SliderNew EAN President, Prof. Paul Boon, identifies brain health, research agenda, and residents as key priorities
On the final day of EAN 2022, the EAN presidency was handed over to the new president, Prof. Paul Boon, chairman and senior full professor of neurology at Ghent University Hospital and Director of 4Brain at Ghent University.